Abstract
Maternal exposure to methylmercury can adversely affect fetal neurodevelopment. Long-term mercury exposure is best estimated by hair measurement of the metal. The authors analyzed the appropriateness of therapeutic monitoring of hair mercury in women of reproductive age using widely accepted criteria for therapeutic drug monitoring. The analysis reveals that such monitoring can help protect babies from long-term adverse effects, while ensuring appropriate maternal fish consumption.